Alan Frazer, PhD
- 4Articles
- 7.5KReads
- 1997–2001Active
About
Alan Frazer, PhD, has published extensively on the pharmacological treatment of major depressive disorder, focusing on serotonergic and noradrenergic reuptake inhibitors. His work explores the prediction of clinical effects based on in vitro potencies and the role of norepinephrine in antidepressant action. Frazer's contributions to psychopharmacology appeared in Psychiatrist.com between 1997 and 2001.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
